Intravenous Gammaglobulin Inhibits Encephalitogenic Potential of Pathogenic T Cells and Interferes with their Trafficking to the Central Nervous System, Implicating Sphingosine-1 Phosphate Receptor 1–Mammalian Target of Rapamycin Axis - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Journal of Immunology Année : 2013

Intravenous Gammaglobulin Inhibits Encephalitogenic Potential of Pathogenic T Cells and Interferes with their Trafficking to the Central Nervous System, Implicating Sphingosine-1 Phosphate Receptor 1–Mammalian Target of Rapamycin Axis

Domaines

Immunité innée Allergologie

Jagadeesh Bayry  : Connectez-vous pour contacter le contributeur

https://inserm.hal.science/inserm-02455535

Soumis le : dimanche 26 janvier 2020-11:38:48

Dernière modification le : vendredi 19 avril 2024-16:18:58

Consulter le texte intégral

Dates et versions

inserm-02455535 , version 1 (26-01-2020)

Identifiants

Citer

Shivashankar Othy, Pushpa Hegde, Selma Topçu, Meenu Sharma, Mohan S Maddur, et al.. Intravenous Gammaglobulin Inhibits Encephalitogenic Potential of Pathogenic T Cells and Interferes with their Trafficking to the Central Nervous System, Implicating Sphingosine-1 Phosphate Receptor 1–Mammalian Target of Rapamycin Axis. Journal of Immunology, 2013, 190 (9), pp.4535-4541. ⟨10.4049/jimmunol.1201965⟩. ⟨inserm-02455535⟩

Exporter

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

INSERM UNIV-PARIS7 UPMC EPHE CNRS CORDELIERS CIMI PSL SORBONNE-UNIVERSITE SU-MEDECINE SU-SCIENCES UP-SANTE
28 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More